Compare Air Products & Chemicals, Inc. (APD) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Air Products & Chemicals, Inc. vs Citius Pharmaceuticals Inc — how do they compare? Air Products & Chemicals, Inc. trades at $308.56 (market cap $68.88B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Air Products & Chemicals, Inc. is far larger — about 3442.3× Citius Pharmaceuticals Inc's market cap, and Air Products & Chemicals, Inc. pays a 2.34% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| APD | CTXR | |
|---|---|---|
Market Cap | $68.88B | $20.01M |
Sector | Basic Materials | Health |
52-Week High | $314.19 | $1.82 |
52-Week Low | $230.42 | $0.48 |
Enterprise Value | $86.06B | $16.23M |
Dividend Yield | 2.34% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CTXR is trading at $0.68, up 6.28% today, with a bullish technical signal from moving averages. The company shows strong commercial momentum with LYMPHIR cancer treatment revenue reaching $5.6 million in H1 2026, though it remains unprofitable with a -823% net margin. Analyst consensus is strongly bullish with 83% buy ratings.
The outlook depends on LYMPHIR's commercial success offsetting deep losses. Near-term catalysts include expanded market access and combination therapy data, but high cash burn and execution risks require monitoring. The stock offers speculative growth potential in oncology but carries significant financial risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Air Products & Chemicals, Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.
Read more on APD →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
